Quick Answer
NORTHWEST BIOTHERAPEUTICS INC reported Net Income of -$83.78 million for fiscal year 2024.
NORTHWEST BIOTHERAPEUTICS INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | -$83.78M | -33.8% |
| 2023 | -$62.60M | +40.4% |
| 2022 | -$105.03M | -158.6% |
| 2021 | $179.13M | +133.8% |
| 2020 | -$529.82M | -2445.7% |
| 2019 | -$20.81M | +41.9% |
| 2018 | -$35.79M | +51.1% |
| 2017 | -$73.14M | +8.8% |
| 2016 | -$80.21M | +30.1% |
| 2015 | -$114.74M | +15.4% |
| 2014 | -$135.63M | -106.2% |
| 2013 | -$65.79M | +2.3% |
| 2012 | -$67.32M | -105.1% |
| 2011 | -$32.83M | -20.0% |
| 2010 | -$27.37M | -1.5% |
| 2009 | -$26.95M | -20.7% |
| 2008 | -$22.33M | -5.1% |
| 2007 | -$21.25M | -1423.1% |
| 2006 | -$1.40M | +86.0% |
| 2005 | -$9.94M | -16.8% |
| 2004 | -$8.51M | -47.9% |
| 2003 | -$5.75M | +55.1% |
| 2002 | -$12.80M | -17.0% |
| 2001 | -$10.94M | +14.4% |
| 2000 | -$12.78M | -127.8% |
| 1999 | -$5.61M | -18.9% |
| 1998 | -$4.72M | -84.3% |
| 1997 | -$2.56M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$26.83M | -38.5% | -74.5% |
| June 30, 2025 | -$15.38M | +13.9% | +20.5% |
| March 31, 2025 | -$19.34M | -5.6% | +0.2% |
| September 30, 2024 | -$19.37M | +17.6% | -8.4% |
| June 30, 2024 | -$17.87M | -23.7% | +2.4% |
| March 31, 2024 | -$18.31M | -71.9% | +22.1% |
| September 30, 2023 | -$23.52M | +28.4% | -62.8% |
| June 30, 2023 | -$14.45M | +51.3% | -35.6% |
- NORTHWEST BIOTHERAPEUTICS INC showed a decrease of -33.8% in Net Income compared to the prior fiscal year.
- Over the 1997–2024 period, NORTHWEST BIOTHERAPEUTICS INC’s net income has declined by 3172.6% (from -$2.56 million to -$83.78 million).
- The most recent figure is from NORTHWEST BIOTHERAPEUTICS INC’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: